Combination of metformin plus TKI vs. TKI alone in EGFR(+) LUNG adenocarcinoma: A randomized phase II study.

Rodriguez, OGA; Barron, FB; Padilla, MAS; Ramirez-Tirado, LA; Flores-Estrada, D; Cruz-Rico, G

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):